Featured

Highly Cited Researchers 2022: Using deeper qualitative analysis to help spot research misconduct

David Pendlebury

Head of Research Analysis at the Institute for Scientific Information

arrow_forward Read more
Academia and Government
Citation Laureates 2022: Nobel class researchers who are changing the world
arrow_forward Read more
Intellectual Property
Top 100 New Brands in 2022
arrow_forward Read more
Intellectual Property
December 9, 2022

Your Unitary Patent Checklist: Five steps to take to prepare
Anton Wallner
Global Head of European Patent Validations
Clarivate
Life Sciences and Healthcare
December 6, 2022

Five IDNs to watch in 2023
Valerie E. Pillo
Senior Healthcare Research & Data Analyst
Clarivate
Clarivate Insights
November 22, 2022

Margaret Goldstein: A 40-year journey of discovery
Academia and Government
November 18, 2022

Clarivate releases Annual G20 Scorecard of research performance for 2022
Ann Beynon
Strategic Alliances and Engagement Manager
Clarivate
Life Sciences and Healthcare
November 16, 2022

Modeling the monkeypox breakout: Mutation rates and the potential for outbreaks
Thirumugam Muthuvel
Clarivate Consultant
Clarivate
Academia and Government
November 15, 2022

Highly Cited Researchers 2022: Using deeper qualitative analysis to help spot research misconduct
David Pendlebury
Head of Research Analysis at the Institute for Scientific Information
Clarivate
Academia and Government
November 14, 2022

Climate change education platform highlights Web of Science data at COP27
Ann Beynon
Strategic Alliances and Engagement Manager
Clarivate
Intellectual Property
November 14, 2022

Choosing an IP support services partner is easier than you think
Andrew Proctor
VP Patent Services
Clarivate
Life Sciences and Healthcare
November 10, 2022

Bringing the patient voice into clinical trials with clinical outcome assessments
Helen Kitchen
Vice President, Clinical Outcome Assessment
Clarivate
Clarivate Insights
November 9, 2022

Scott McKay: Mapping the evolution of trademark research
Life Sciences and Healthcare
November 8, 2022

Seven RNA technology companies to keep an eye on
Matthew Arnold
Principal Analyst
Clarivate
Life Sciences and Healthcare
October 31, 2022

Digital therapeutics elbow their way into U.S. health plans
Chris Lewis
Primary Research Manager, U.S. Access & Reimbursement
Clarivate
Academia and Government
October 26, 2022

Renewable energy: Strategizing a better, more sustainable world [Report]
Ed White
Chief Analyst and VP, IP and Innovation Research
Clarivate
Life Sciences and Healthcare
October 10, 2022

ESMO 2022: Ten key takeaways on Europe’s top oncology event
Khurram Nawaz
Senior Director, Oncology Market Assessment
Clarivate
Intellectual Property
October 6, 2022

IP management: There’s significant value in getting it right
Glen Nath
Head of IP Software Products and Consulting
Clarivate